Literature DB >> 15695668

Diagnosis of congenital toxoplasmosis by two-dimensional immunoblot differentiation of mother and child immunoglobulin g profiles.

Henrik Vedel Nielsen1, Dorte Remmer Schmidt, Eskild Petersen.   

Abstract

Differentiation between the specific immunoglobulin G (IgG) response to Toxoplasma gondii by a mother and her newborn child is helpful in the diagnosis of congenital infection with T. gondii in newborns without T. gondii-specific IgM and/or IgA antibodies at birth. Previous methods include immunoblotting and complexing T. gondii antigen with the sera from the mother and child and comparing the bands after electrophoresis. We developed a two-dimensional immunoblotting (2DIB) method with T. gondii RH strain tachyzoite antigen and validated the method with sera from 11 children identified through the neonatal screening program for congenital toxoplasmosis in Denmark. The children were identified by using Toxoplasma-specific IgM antibodies at the screening test, but the presence of T. gondii-specific IgM and/or IgA antibodies could not be confirmed at the subsequent serum sample tested. The children were monitored for at least 12 months, and in seven of eight patients monitored for 12 months the results of the 2DIB-predicted congenital infection were confirmed by the presence of persistent Toxoplasma-specific IgG antibodies. 2DIB is a sensitive technique that allows early differentiation between passively transferred maternal T. gondii-specific IgG antibodies and antibodies synthesized by the newborn child.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15695668      PMCID: PMC548042          DOI: 10.1128/JCM.43.2.711-715.2005

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  17 in total

1.  Characterisation of global protein expression by two-dimensional electrophoresis and mass spectrometry: proteomics of Toxoplasma gondii.

Authors:  A M Cohen; K Rumpel; G H Coombs; J M Wastling
Journal:  Int J Parasitol       Date:  2002-01       Impact factor: 3.981

2.  Usefulness of Western blot in serological follow-up of newborns suspected of congenital toxoplasmosis.

Authors:  D Tissot Dupont; H Fricker-Hidalgo; M P Brenier-Pinchart; C Bost-Bru; P Ambroise-Thomas; H Pelloux
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-02-18       Impact factor: 3.267

Review 3.  Recent developments for diagnosis of toxoplasmosis.

Authors:  Jack S Remington; Philippe Thulliez; Jose G Montoya
Journal:  J Clin Microbiol       Date:  2004-03       Impact factor: 5.948

4.  Automated time-resolved immunofluorometric assay for Toxoplasma gondii-specific IgM and IgA antibodies: study of more than 130,000 filter-paper blood-spot samples from newborns.

Authors:  Tina Sørensen; Johanne Spenter; Irakli Jaliashvili; Michael Christiansen; Bent Nørgaard-Pedersen; Eskild Petersen
Journal:  Clin Chem       Date:  2002-11       Impact factor: 8.327

5.  Performance of a Western blot assay to compare mother and newborn anti-Toxoplasma antibodies for the early neonatal diagnosis of congenital toxoplasmosis.

Authors:  F Robert-Gangneux; V Commerce; C Tourte-Schaefer; J Dupouy-Camet
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1999-09       Impact factor: 3.267

6.  Feasibility of neonatal screening for toxoplasma infection in the absence of prenatal treatment. Danish Congenital Toxoplasmosis Study Group .

Authors:  M Lebech; O Andersen; N C Christensen; J Hertel; H E Nielsen; B Peitersen; C Rechnitzer; S O Larsen; B Nørgaard-Pedersen; E Petersen
Journal:  Lancet       Date:  1999-05-29       Impact factor: 79.321

7.  Comparative immunoglobulin G antibody profiles between mother and child (CGMC test) for early diagnosis of congenital toxoplasmosis.

Authors:  U Gross; C G Lüder; V Hendgen; C Heeg; I Sauer; A Weidner; D Krczal; G Enders
Journal:  J Clin Microbiol       Date:  2000-10       Impact factor: 5.948

8.  Serological rebound in congenital toxoplasmosis: long-term follow-up of 133 children.

Authors:  M Wallon; G Cozon; R Ecochard; P Lewin; F Peyron
Journal:  Eur J Pediatr       Date:  2001-09       Impact factor: 3.183

9.  Evaluation of a commercial IgG/IgM Western blot assay for early postnatal diagnosis of congenital toxoplasmosis.

Authors:  V Rilling; K Dietz; D Krczal; F Knotek; G Enders
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-03-05       Impact factor: 3.267

10.  Newborn screening for congenital infectious diseases.

Authors:  Eurico Camargo Neto; Rosélia Rubin; Jacqueline Schulte; Roberto Giugliani
Journal:  Emerg Infect Dis       Date:  2004-06       Impact factor: 6.883

View more
  5 in total

1.  Arboprotozoae.

Authors: 
Journal:  Transfus Med Hemother       Date:  2009       Impact factor: 3.747

2.  Use of MAG1 recombinant antigen for diagnosis of Toxoplasma gondii infection in humans.

Authors:  Lucyna Holec; Elzbieta Hiszczyńska-Sawicka; Artur Gasior; Anna Brillowska-Dabrowska; Józef Kur
Journal:  Clin Vaccine Immunol       Date:  2007-01-03

3.  Use of recombinant antigens for early postnatal diagnosis of congenital toxoplasmosis.

Authors:  Wilma Buffolano; Elisa Beghetto; Mariassunta Del Pezzo; Andrea Spadoni; Manlio Di Cristina; Eskild Petersen; Nicola Gargano
Journal:  J Clin Microbiol       Date:  2005-12       Impact factor: 5.948

4.  Congenital toxoplasmosis--a report on the Danish neonatal screening programme 1999-2007.

Authors:  Dennis Röser; Henrik Vedel Nielsen; Eskild Petersen; Peter Saugmann-Jensen; Bent Nørgaard-Pedersen; Peter Bent Nørgaard-Pedersen
Journal:  J Inherit Metab Dis       Date:  2010-06-29       Impact factor: 4.982

5.  Low Prevalence of Antibodies Against Toxoplasma gondii in Chinese Populations.

Authors:  Shilin Xin; Ruijing Su; Nan Jiang; Longxian Zhang; Yurong Yang
Journal:  Front Cell Infect Microbiol       Date:  2020-06-23       Impact factor: 5.293

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.